DOI:
10.1055/s-00000058
Planta Medica
LinksClose Window
References
Wang G, Wei J, Guan Y, Jin N, Mao J, Wang X.
Peroxisome proliferator-activated receptor-γ agonist rosiglitazone
reduces clinical inflammatory responses in type 2 diabetes with coronary artery
disease after coronary angioplasty.
Metabolism 2005;
54: 590-597
Search in:
Access:
We do not assume any responsibility for the contents of the web pages of other providers.